Kellnerova Amends Autolus Therapeutics Stake Filing

Ticker: AUTL · Form: SC 13D/A · Filed: 2024-03-25T00:00:00.000Z

Sentiment: neutral

Topics: 13d-filing, shareholder-activity, biotech

Related Tickers: AUTL

TL;DR

Kellnerova's group updated their Autolus stake filing on 3/25/24. Watch for changes.

AI Summary

Renata Kellnerova, through PPF Biotech B.V. and PPF Group N.V., has amended their Schedule 13D filing for Autolus Therapeutics plc on March 25, 2024. This amendment likely reflects changes in their beneficial ownership or intentions regarding the company's securities.

Why It Matters

Changes in significant shareholder filings like this can signal shifts in control or investment strategy, potentially impacting the stock price and future corporate actions of Autolus Therapeutics.

Risk Assessment

Risk Level: medium — Amendments to 13D filings can indicate significant changes in a major shareholder's position or intentions, which could lead to market volatility.

Key Players & Entities

FAQ

What specific changes were made in Amendment No. 9 to the Schedule 13D filing for Autolus Therapeutics plc?

The filing does not specify the exact changes made in Amendment No. 9, only that it is an amendment to the Schedule 13D.

Who are the primary entities filing this Schedule 13D/A?

The primary entities are Renata Kellnerova, PPF Biotech B.V., and PPF Group N.V.

What is the CUSIP number for Autolus Therapeutics plc's American Depositary Shares?

The CUSIP number is 05280R100.

When was this amendment filed with the SEC?

This amendment was filed on March 25, 2024.

What is the business address of Autolus Therapeutics plc?

The business address is The Mediaworks, 191 Wood Lane, London, W12 7FP.

From the Filing

0001213900-24-025536.txt : 20240325 0001213900-24-025536.hdr.sgml : 20240325 20240325161031 ACCESSION NUMBER: 0001213900-24-025536 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240325 DATE AS OF CHANGE: 20240325 GROUP MEMBERS: PPF BIOTECH B.V. GROUP MEMBERS: PPF GROUP N.V. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Autolus Therapeutics plc CENTRAL INDEX KEY: 0001730463 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-90550 FILM NUMBER: 24779311 BUSINESS ADDRESS: STREET 1: THE MEDIAWORKS STREET 2: 191 WOOD LANE CITY: LONDON STATE: X0 ZIP: W12 7FP BUSINESS PHONE: 44 20 3829 6230 MAIL ADDRESS: STREET 1: THE MEDIAWORKS STREET 2: 191 WOOD LANE CITY: LONDON STATE: X0 ZIP: W12 7FP FORMER COMPANY: FORMER CONFORMED NAME: Autolus Therapeutics Ltd DATE OF NAME CHANGE: 20180205 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Kellnerova Renata CENTRAL INDEX KEY: 0001952063 ORGANIZATION NAME: FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: BREZOVSKA 509 CITY: VRANE NAD VLTAVOU STATE: 2N ZIP: 25246 SC 13D/A 1 ea0202429-13da9kell_autolus.htm AMENDMENT NO. 9 TO SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 9) AUTOLUS THERAPEUTICS PLC (Name of Issuer) American Depositary Shares, each representing one ordinary share, nominal value $0.000042 per share, and ordinary shares, nominal value $0.000042 per share (Title of Class of Securities) 05280R100** (CUSIP Number) c/o Lubomír Král PPF a.s. Evropská 2690/17 P.O. Box 177 160 41 Praha 6 Czech Republic Tel: (+420) 224 174 067 With copies to: Scott Levi White & Case LLP 1221 Avenue of the Americas New York, NY 10020-1095 +1 (212) 819 8200 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) March 21, 2024 (Date of Event Which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐ Note : Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. ** There is no CUSIP number assigned to the Ordinary Shares. CUSIP number 05280R100 has been assigned to the American Depositary Shares (“ADSs”) of the Company, which are quoted on the Nasdaq Global Select Market under the symbol “AUTL.” Each ADS represents 1 Ordinary Share. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 05280R100 1 NAME OF REPORTING PERSONS Renata Kellnerova 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐ (b) ☐ 3 SEC USE ONLY 4 SOURCE OF FUNDS AF 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ☐ 6 CITIZENSHIP OR PLACE OF ORGANIZATION Czech Republic NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 0 8 SHARED VOTING

View on Read The Filing